<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03847610</url>
  </required_header>
  <id_info>
    <org_study_id>17IC4051</org_study_id>
    <secondary_id>236047</secondary_id>
    <secondary_id>18/LO/0054</secondary_id>
    <nct_id>NCT03847610</nct_id>
  </id_info>
  <brief_title>Minimally Invasive Sensing of Beta-lactam Antibiotics</brief_title>
  <acronym>MISBL</acronym>
  <official_title>Microneedle Sensing of Beta-lactam Antibiotic Concentrations in Human Interstitial Fluid</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Imperial College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Imperial College London</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is an in-house feasibility study of a microneedle biosensor developed within&#xD;
      Imperial College London.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Outline of the study:&#xD;
&#xD;
      This study will comprise the recruitment of 10-15 healthy volunteers. They will be recruited&#xD;
      to test the microneedle biosensors and undergo rich plasma sampling with or without tissue&#xD;
      microdialysis to calibrate the microneedle biosensor and evaluate its accuracy against&#xD;
      current gold standards (i.e. plasma drug concentration and tissue microdialysis). This study&#xD;
      will take place at the Imperial Clinical Research Facility (CRF).&#xD;
&#xD;
      Patient identification:&#xD;
&#xD;
      Healthy volunteers will be recruited from a healthy volunteer database held within Imperial&#xD;
      College London and via identification of participants within the College. An initial&#xD;
      advertisement e-mail will be sent and individuals responding will then followed up by&#xD;
      telephone and invited to attend a screening visit at the Imperial CRF. They will be sent the&#xD;
      participant information leaflet in advance of this meeting to give them time to consider the&#xD;
      information. At this visit a member of the research team will go through the study procedure&#xD;
      and answer any questions that the participant has.&#xD;
&#xD;
      Consent procedure:&#xD;
&#xD;
      Healthy volunteers who wish to participate in the study after considering the participant&#xD;
      information leaflet will be consented by a trained researcher who will complete the&#xD;
      eligibility screening for inclusion into the study.&#xD;
&#xD;
      Study Methodology:&#xD;
&#xD;
      10-15 healthy volunteers will be invited to participate in an exploratory study of the sensor&#xD;
      device. On their screening visit routine blood tests will be performed to ensure that the&#xD;
      participant is not anaemic and has no evidence of current infection. Before the study day the&#xD;
      participant will be required to take 5 doses of oral penicillin to ensure that they are at&#xD;
      steady state and to allow for stabilization of tissue distribution. Four of these doses will&#xD;
      be taken at 6-hour intervals on the day before they attend the Imperial CRF. The final dose&#xD;
      will be taken on the morning that they attend.&#xD;
&#xD;
      On arrival at the study centre the participant will have a microneedle biosensor sited for up&#xD;
      to 12 hours whilst receiving antimicrobial therapy. The sensor will be sited peripherally (on&#xD;
      an arm or leg). In a small number of cases the sensor may be sited centrally on the torso.&#xD;
      These sensors are connected to potentiostat devices that records data, which can then be&#xD;
      downloaded onto a computer for analysis.&#xD;
&#xD;
      Following arrival on the study day and placing of the sensor devices, a cannula will be sited&#xD;
      for phlebotomy and a baseline beta-lactam antibiotic concentration will be taken. A&#xD;
      microdialysis fibre will also be inserted peripherally into tissue close to the microneedle&#xD;
      device to allow gold standard analysis of tissue antibiotic concentration. The participant&#xD;
      will then undergo rich plasma drug sampling with up to 15 blood tests taken over a 6-12 hour&#xD;
      period.&#xD;
&#xD;
      Each blood test will involve the collection of 3mL extra blood (&lt;1 teaspoons) via a cannula&#xD;
      which will be cited on commencement of the study. Microdialysis may be performed in all&#xD;
      participants who consent to this as a gold standard for determining tissue drug&#xD;
      concentrations. If they do not consent for this, the study will be able to continue without&#xD;
      microdialysis being performed. Participants will also be required to complete a visual&#xD;
      analogue scale every hour testing their level of discomfort due to the microneedle sensor&#xD;
      device and a member of the research team will document any redness or skin changes around the&#xD;
      site of the device. A further dose of penicillin will be given approximately 6 hours into the&#xD;
      study.&#xD;
&#xD;
      Time points for the blood sampling are planned to initially be taken at (0, 15, 30, 45, 60,&#xD;
      90, 120, 150, 180, 210, 240, 360, 480, 600, 720 minutes). However, following initial&#xD;
      pharmacokinetic (PK) analysis a D-optimal design will be employed using Pmetrics and BestDose&#xD;
      PK software to determine the optimal time points for blood PK analysis. This will be&#xD;
      performed by a trained member of the research team.&#xD;
&#xD;
      Clinically relevant data including demographic, co-morbidity, and medication data will be&#xD;
      collected by members of the research team from the participant.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 12, 2018</start_date>
  <completion_date type="Actual">August 10, 2018</completion_date>
  <primary_completion_date type="Actual">August 10, 2018</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of the Biosensors Ability to Track Phenoxymethylpenicillin Concentrations Compared to Observations Made by Microdialysis and Blood Sampling</measure>
    <time_frame>Up to 12 hours</time_frame>
    <description>Bland-Altman plot to describe agreement between interstitial phenoxymethylpenicillin concentrations and microneedle data (mean difference between microneedle and microdialysis measurements)</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">11</enrollment>
  <condition>Healthy Volunteers</condition>
  <arm_group>
    <arm_group_label>Healthy volunteer</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Phenoxymethyl Penicillin</intervention_name>
    <description>Phenoxymethylpenicillin tablets, 500mg every six hours for six doses, starting the day before study</description>
    <arm_group_label>Healthy volunteer</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Microneedle array</intervention_name>
    <description>The microneedle biosensor will be sited peripherally (on the non-dominant arm) for the duration of the study. It will then be removed.</description>
    <arm_group_label>Healthy volunteer</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult &gt;18 years old&#xD;
&#xD;
          -  Healthy with no evidence of active infection&#xD;
&#xD;
          -  Previously received penicillin with no adverse effects&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  High risk of skin soft tissue infection or local skin and soft tissue infection near&#xD;
             sensor site&#xD;
&#xD;
          -  Previous history of allergies to adhesive strips or active dermatitis&#xD;
&#xD;
          -  Penicillin allergy or previous adverse event whilst receiving penicillin&#xD;
&#xD;
          -  Anaemia on screening bloods (defined as haemoglobin &lt;13 g/dL in males and &lt;12 g/dL in&#xD;
             females)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alison H Holmes, MD MPH MBBS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Health Protection Research Unit in HCAI &amp; AMR</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>NIHR Imperial CRF</name>
      <address>
        <city>London</city>
        <zip>W12 0HS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>February 7, 2019</study_first_submitted>
  <study_first_submitted_qc>February 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 20, 2019</study_first_posted>
  <results_first_submitted>November 6, 2020</results_first_submitted>
  <results_first_submitted_qc>December 3, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">December 29, 2020</results_first_posted>
  <last_update_submitted>December 3, 2020</last_update_submitted>
  <last_update_submitted_qc>December 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pharmacokinetics</keyword>
  <keyword>Penicillin V</keyword>
  <keyword>Penicillins</keyword>
  <keyword>Proof of Concept Study</keyword>
  <keyword>Clinical Trial, Phase I</keyword>
  <keyword>Microneedle array</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Penicillins</mesh_term>
    <mesh_term>Penicillin V</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>December 6, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/10/NCT03847610/Prot_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>One volunteer withdrew consent to undergo microdialysis on the study day and was withdrawn from the analysis. The participant did not cite a reason for declining microdialysis catheter insertion. Therefore, ten volunteers were included in the study.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Healthy Volunteer</title>
          <description>Phenoxymethyl Penicillin: Phenoxymethylpenicillin tablets, 500mg every six hours for six doses, starting the day before study&#xD;
Microneedle array: The microneedle biosensor will be sited peripherally (on the non-dominant arm) for the duration of the study. It will then be removed.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Healthy Volunteer</title>
          <description>Phenoxymethyl Penicillin: Phenoxymethylpenicillin tablets, 500mg every six hours for six doses, starting the day before study&#xD;
Microneedle array: The microneedle biosensor will be sited peripherally (on the non-dominant arm) for the duration of the study. It will then be removed.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42" spread="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United Kingdom</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24" spread="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Creatinine clearance</title>
          <units>mL/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="114" spread="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height</title>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="174" spread="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="74" spread="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Assessment of the Biosensors Ability to Track Phenoxymethylpenicillin Concentrations Compared to Observations Made by Microdialysis and Blood Sampling</title>
        <description>Bland-Altman plot to describe agreement between interstitial phenoxymethylpenicillin concentrations and microneedle data (mean difference between microneedle and microdialysis measurements)</description>
        <time_frame>Up to 12 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Healthy Volunteer</title>
            <description>Phenoxymethyl Penicillin: Phenoxymethylpenicillin tablets, 500mg every six hours for six doses, starting the day before study&#xD;
Microneedle array: The microneedle biosensor will be sited peripherally (on the non-dominant arm) for the duration of the study. It will then be removed.</description>
          </group>
        </group_list>
        <measure>
          <title>Assessment of the Biosensors Ability to Track Phenoxymethylpenicillin Concentrations Compared to Observations Made by Microdialysis and Blood Sampling</title>
          <description>Bland-Altman plot to describe agreement between interstitial phenoxymethylpenicillin concentrations and microneedle data (mean difference between microneedle and microdialysis measurements)</description>
          <units>mg/L</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.16" lower_limit="-1.3" upper_limit="0.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Study day -1, and on the study day for each participant</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Healthy Volunteer</title>
          <description>Phenoxymethyl Penicillin: Phenoxymethylpenicillin tablets, 500mg every six hours for six doses, starting the day before study&#xD;
Microneedle array: The microneedle biosensor will be sited peripherally (on the non-dominant arm) for the duration of the study. It will then be removed.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Richard Wilson</name_or_title>
      <organization>Imperial College London</organization>
      <phone>02033132732</phone>
      <email>richard.wilson@imperial.ac.uk</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

